{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:51:23Z","timestamp":1790077883036,"version":"4.0.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.diagmicrobio.2008.12.013","type":"journal-article","created":{"date-parts":[[2009,3,18]],"date-time":"2009-03-18T10:13:19Z","timestamp":1237371199000},"page":"361-364","source":"Crossref","is-referenced-by-count":12,"title":["A comparison of the fungicidal activity of amphotericin B and posaconazole against Zygomycetes in vitro"],"prefix":"10.1016","volume":"63","author":[{"given":"Suganthini","family":"Krishnan-Natesan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias K.","family":"Manavathu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J.","family":"Alangaden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranatharthi H.","family":"Chandrasekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2008.12.013_bib1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/jac\/dkg020","article-title":"In vitro susceptibilities of Zygomycetes to conventional and new antifungals","volume":"51","author":"Dannaoui","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.12.013_bib2","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1128\/AAC.46.6.1953-1959.2002","article-title":"Efficacy of antifungal therapy in a nonneutropenic murine model of zygomycosis","volume":"46","author":"Dannaoui","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.12.013_bib3","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.1128\/JCM.43.10.5243-5246.2005","article-title":"Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M38-A document) for amphotericin B, itraconazole, posaconazole and voriconazole","author":"Espinel-Ingroff","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2008.12.013_bib4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/jac\/33.2.369","article-title":"Treatment of murine pulmonary mucormycosis with SCH 42427, a broad-spectrum triazole antifungal drug","volume":"33","author":"Goldani","year":"1994","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.12.013_bib5","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00001432-200412000-00003","article-title":"Zygomycosis (mucormycosis): emerging clinical importance and new treatments","volume":"17","author":"Greenberg","year":"2004","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2008.12.013_bib6","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1128\/AAC.50.1.126-133.2006","article-title":"Posaconazole as salvage therapy for zygomycosis","volume":"50","author":"Greenberg","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.12.013_bib7","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1368-5031.2004.00167.x","article-title":"Posaconazole: a potent, extended-spectrum triazole antifungal for the treatment of serious fungal infections","volume":"58","author":"Herbrecht","year":"2004","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.diagmicrobio.2008.12.013_bib8","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1086\/313803","article-title":"Zygomycosis in the 1990s in a tertiary-care cancer center","volume":"30","author":"Kontoyiannis","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2008.12.013_bib9","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/428780","article-title":"Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases","volume":"191","author":"Kontoyiannis","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2008.12.013_bib10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/A:1006970503053","article-title":"In vitro activity of a new triazole antifungal agent, Sch 56592, against clinical isolates of filamentous fungi","volume":"141","author":"Marco","year":"1998","journal-title":"Mycopathologia"},{"key":"10.1016\/j.diagmicrobio.2008.12.013_bib11","first-page":"207","article-title":"Mucormycosis in hematologic patients","volume":"89","author":"Pagano","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.diagmicrobio.2008.12.013_bib12","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/jac\/dki288","article-title":"Activity of posaconazole in the treatment of central nervous system fungal infections","volume":"56","author":"Pitisuttithum","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.12.013_bib13","series-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi","author":"Rex","year":"2008"},{"key":"10.1016\/j.diagmicrobio.2008.12.013_bib14","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1128\/CMR.13.2.236-301.2000","article-title":"Zygomycetes in human disease","volume":"13","author":"Ribes","year":"2000","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.diagmicrobio.2008.12.013_bib15","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2008.12.013_bib16","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1128\/AAC.46.5.1581-1582.2002","article-title":"In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of Zygomycetes","volume":"46","author":"Sun","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.12.013_bib17","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1128\/AAC.46.7.2310-2312.2002","article-title":"In vivo activity of posaconazole against Mucor spp. in an immunosuppressed mouse model","volume":"46","author":"Sun","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.12.013_bib18","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1086\/375075","article-title":"Mucormycosis (zygomycosis) in a heart\u2013kidney transplant recipient: recovery after posaconazole therapy","volume":"36","author":"Tobon","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2008.12.013_bib19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0924-8579(01)00363-6","article-title":"In vitro antifungal activity of posaconazole against various pathogenic fungi","volume":"18","author":"Uchida","year":"2001","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.diagmicrobio.2008.12.013_bib20","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ki.1989.301","article-title":"Effects of deferoxamine, feroxamine and iron on experimental mucormycosis (zygomycosis)","volume":"36","author":"Van Cutsem","year":"1989","journal-title":"Kidney Int."},{"key":"10.1016\/j.diagmicrobio.2008.12.013_bib21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000238681","article-title":"Treatment of experimental zygomycosis in guinea pigs with azoles and with amphotericin B","volume":"35","author":"Van Cutsem","year":"1989","journal-title":"Chemotherapy"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889308005324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889308005324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T01:59:46Z","timestamp":1545357586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889308005324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0732889308005324"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2008.12.013","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}